Why this time no c-warrants. the last c-warrants orchestrated the drop; outstanding shares went from 3 million to over 70 million.
This time we see no further dilution trough april. dilution only starts on late april.read the fillings
Shareprice is going to between $3.4 and $5.95 after R/S Between 3.2 en 5.2 million outstanding.
Thats a rediculous low sharecount when fda hits. only $2 millon dilution before the summer thats a fact read the fillings.thats only between 500,000 and 750,000 shares for 3 months
Market can absorp this in no time.
So either way after FDA clearences shareprice is going to be higher then it is now.